Beleaguered biotech company Elan announced today it will report its first-quarter financial results on April 28th.
The results will be keenly awaited following Elan's most recent share price collapse. Elan shares fell more than 70 per cent after it emerged that three patients died while being treated with the company's MS drug Tysabri.
The results will be followed by a conference call at 1:30pm Irish time for analysts.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to the public.
Elan will hold its AGM on May 26th in the Westin Hotel, Westmoreland Street, Dublin 2.
